Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Reference only. Not financial advice. No brokerage order is placed.
Independent agent review — valuation, statement audit, and earnings read on the latest filing.
TECH's actual catalyst was a FY earnings gap in June (already fully reflected at $72.54 highs); today's 8-K is routine governance with no new fundamental content, making this a monitor-not-chase setup pending next earnings confirmation.
Bull case: Bio-Techne is a high-quality, high-margin specialty biologics tools franchisor with sticky customer relationships (protein/antibody reagents are low-cost, high-switching-cost inputs). The FY earnings gap combined with 3-month tight consolidation at highs suggests institutions have absorbed supply and view the current level as a new fair-value floor. If biopharma R&D budgets continue recovering, TECH has operating leverage to convert incremental revenue into disproportionate earnings growth given its fixed-cost structure.
Bear case: The stock is already at 52-week highs following a 62% 90-day rally — most of the good news is priced in. The current 8-K adds zero new fundamental information. Without visible P/E or EV/Sales multiples, the stock could be trading at 35–45x forward earnings, leaving little margin of safety if the sector recovery stalls, biopharma customers cut R&D again, or a macro risk-off event compresses growth-stock multiples. The flat-line price action at $70–72 since June could also reflect sellers matching buyers rather than genuine accumulation.
| Date | List | Next-day max run | Next-day close | Hit +2%? |
|---|---|---|---|---|
| 2026-09-16 | sec_top_gappers | +0.2% | +0.1% | — |
| 2026-09-16 | sec_top_moat_emerging | +0.2% | +0.1% | — |
| 2026-09-15 | sec_top_gappers | +0.0% | -0.0% | — |
| 2026-09-15 | sec_top_moat_emerging | +0.0% | -0.0% | — |
| 2026-09-14 | sec_top_gappers | +0.2% | +0.1% | — |
| 2026-09-14 | sec_top_moat_emerging | +0.2% | +0.1% | — |
| 2026-09-11 | sec_top_gappers | +0.2% | +0.2% | — |
| 2026-09-11 | sec_top_moat_emerging | +0.2% | +0.2% | — |
| 2026-09-10 | sec_top_gappers | +0.4% | +0.1% | — |
| 2026-09-10 | sec_top_moat_emerging | +0.4% | +0.1% | — |
| 2026-09-04 | sec_top_gappers | +0.0% | -0.2% | — |
| 2026-09-04 | sec_top_moat_emerging | +0.0% | -0.2% | — |
No recent earnings event.
You came here for TECH. You found it after it moved, the same way everyone else did.
Tier 1 setups touched +2% intraday 48.3% of the time across 344 tracked calls. Baseline for everything else: 40.3%. That is a +8.0 point edge, measured from the NEXT OPEN — the first price you could actually pay, not the prior close. We publish the misses too: https://catalystedgescanner.com/trust/
29 of 30 founding seats left. The price goes up when they are gone.
Become a Founding Member — $99 onceOne payment, access for as long as we run the service. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →